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Although physical activity (PA) is a key element in the prevention and management of type 2
diabetes, many with this chronic disease do not become or remain regularly active. High-quality
studiesestablishingtheimportanceofexerciseandﬁtnessindiabeteswerelackinguntilrecently,
butitisnowwellestablishedthatparticipationinregularPAimprovesbloodglucosecontroland
can prevent or delay type 2 diabetes, along with positively affecting lipids, blood pressure,
cardiovascular events, mortality, and quality of life. Structured interventions combining PA and
modest weight loss have been shown to lower type 2 diabetes risk by up to 58% in high-risk
populations.MostbeneﬁtsofPAondiabetesmanagementarerealizedthroughacuteandchronic
improvements in insulin action, accomplished with both aerobic and resistance training. The
beneﬁts of physical training are discussed, along with recommendations for varying activities,
PA-associated blood glucose management, diabetes prevention, gestational diabetes mellitus,
and safe and effective practices for PA with diabetes-related complications.
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INTRODUCTION
D
iabetes has become a widespread
epidemic, primarily because of the
increasing prevalence and inci-
denceoftype2diabetes.Accordingtothe
Centers for Disease Control and Preven-
tion, in 2007, almost 24 million Ameri-
cans had diabetes, with one-quarter of
those, or six million, undiagnosed (261).
Currently, it is estimated that almost 60
million U.S. residents also have prediabe-
tes, a condition in which blood glucose
(BG) levels are above normal, thus greatly
increasing their risk for type 2 diabetes
(261). Lifetime risk estimates suggest that
one in three Americans born in 2000 or
later will develop diabetes, but in high-
risk ethnic populations, closer to 50%
may develop it (200). Type 2 diabetes is a
signiﬁcant cause of premature mortality
and morbidity related to cardiovascular
disease (CVD), blindness, kidney and
nerve disease, and amputation (261). Al-
though regular physical activity (PA) may
prevent or delay diabetes and its compli-
cations (10,46,89,112,176,208,259,294),
most people with type 2 diabetes are not
active (193).
In this article, the broader term
“physical activity” (deﬁned as “bodily
movement produced by the contraction
of skeletal muscle that substantially in-
creases energy expenditure”) is used in-
terchangeably with “exercise,” which is
deﬁned as “a subset of PA done with the
intention of developing physical ﬁtness
(i.e., cardiovascular [CV], strength, and
ﬂexibility training).” The intent is to rec-
ognize that many types of physical move-
ment may have a positive effect on
physical ﬁtness, morbidity, and mortality
in individuals with type 2 diabetes.
Diagnosis, classiﬁcation, and
etiology of diabetes
Currently, the American Diabetes Associ-
ation (ADA) recommends the use of any
of the following four criteria for diagnos-
ing diabetes: 1) glycated hemoglobin
(A1C) value of 6.5% or higher, 2) fasting
plasma glucose 126 mg/dl (7.0 mmol/
l), 3) 2-h plasma glucose 200 mg/dl
(11.1 mmol/l) during an oral glucose tol-
erance test using 75 g of glucose, and/or
4) classic symptoms of hyperglycemia
(e.g., polyuria, polydipsia, and unex-
plainedweightloss)orhyperglycemiccri-
sis with a random plasma glucose of 200
mg/dl (11.1 mmol/l) or higher. In the ab-
sence of unequivocal hyperglycemia, the
ﬁrst three criteria should be conﬁrmed by
repeat testing (4). Prediabetes is diag-
nosed with an A1C of 5.7–6.4%, fasting
plasma glucose of 100–125 mg/dl (5.6–
6.9 mmol/l; i.e., impaired fasting glucose
[IFG]), or 2-h postload glucose of 140–
199 mg/dl (7.8–11.0 mmol/l; i.e., im-
paired glucose tolerance [IGT]) (4).
The major forms of diabetes can be
categorizedastype1ortype2(4).Intype
1 diabetes, which accounts for 5–10% of
cases, the cause is an absolute deﬁciency
of insulin secretion resulting from auto-
immune destruction of the insulin-
producing cells in the pancreas. Type 2
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combination of the inability of muscle
cells to respond to insulin properly (insu-
lin resistance) and inadequate compensa-
tory insulin secretion. Less common
forms include gestational diabetes melli-
tus (GDM), which is associated with a
40–60% chance of developing type 2 di-
abetes in the next 5–10 years (261). Dia-
betes can also result from genetic defects
in insulin action, pancreatic disease, sur-
gery, infections, and drugs or chemicals
(4,261).
Genetic and environmental factors
are strongly implicated in the develop-
mentoftype2diabetes.Theexactgenetic
defects are complex and not clearly de-
ﬁned(4),butriskincreaseswithage,obe-
sity, and physical inactivity. Type 2
diabetes occurs more frequently in popu-
lations with hypertension or dyslipide-
mia, women with previous GDM, and
non-Caucasian people including Native
Americans, African Americans, Hispanic/
Latinos, Asians, and Paciﬁc Islanders.
Treatment goals in type 2 diabetes
The goal of treatment in type 2 diabetes is
to achieve and maintain optimal BG,
lipid, and blood pressure (BP) levels to
preventordelaychroniccomplicationsof
diabetes (5). Many people with type 2 di-
abetes can achieve BG control by follow-
ing a nutritious meal plan and exercise
program, losing excess weight, imple-
menting necessary self-care behaviors,
and taking oral medications, although
others may need supplemental insulin
(261).DietandPAarecentraltotheman-
agement and prevention of type 2 diabe-
tes because they help treat the associated
glucose, lipid, BP control abnormalities,
as well as aid in weight loss and mainte-
nance. When medications are used to
control type 2 diabetes, they should aug-
ment lifestyle improvements, not replace
them.
ACUTE EFFECTS OF
EXERCISE
Fuel metabolism during exercise
Fuel mobilization, glucose production,
and muscle glycogenolysis. The main-
tenance of normal BG at rest and during
exercise depends largely on the coordina-
tion and integration of the sympathetic
nervous and endocrine systems (250).
Contracting muscles increase uptake of
BG, although BG levels are usually main-
tainedbyglucoseproductionvialivergly-
cogenolysis and gluconeogenesis and
mobilization of alternate fuels, such as
free fatty acids (FFAs) (250,268).
Several factors inﬂuence exercise fuel
use,butthemostimportantaretheinten-
sity and duration of PA (9,29,47,83,111,
133,160,181,241). Any activity causes a
shiftfrompredominantrelianceonFFAat
rest to a blend of fat, glucose, and muscle
glycogen, with a small contribution
from amino acids (15,31). With in-
creasing exercise intensity, there is a
greater reliance on carbohydrate as long
as sufﬁcient amounts are available in
muscle or blood (21,23,47,133). Early
in exercise, glycogen provides the bulk
of the fuel for working muscles. As gly-
cogen stores become depleted, muscles
increase their uptake and use of circu-
lating BG, along with FFA released from
adipose tissue (15,132, 271). Intramus-
cular lipid stores are more readily used
during longer-duration activities and
recovery (23,223,270). Glucose pro-
duction also shifts from hepatic glyco-
genolysis to enhanced gluconeogenesis
as duration increases (250,268).
Evidencestatement. PAcausesincreased
glucose uptake into active muscles bal-
anced by hepatic glucose production,
with a greater reliance on carbohydrate to
fuel muscular activity as intensity in-
creases. The American College of Sports
Medicine (ACSM) evidence category A (see
Tables 1 and 2 for explanation).
Insulin-independent and insulin-
dependent muscle glucose uptake dur-
ingexercise. Therearetwowell-deﬁned
pathways that stimulate glucose uptake
by muscle (96). At rest and postprandi-
ally, its uptake by muscle is insulin de-
pendentandservesprimarilytoreplenish
muscle glycogen stores. During exercise,
contractions increase BG uptake to sup-
plement intramuscular glycogenolysis
(220,227). As the two pathways are dis-
tinct, BG uptake into working muscle is
normal even when insulin-mediated up-
take is impaired in type 2 diabetes
(28,47,293). Muscular BG uptake re-
mains elevated postexercise, with the
contraction-mediated pathway persist-
ing for several hours (86,119) and insulin-
mediated uptake for longer (9,33,141, 226).
Glucose transport into skeletal mus-
cle is accomplished via GLUT proteins,
with GLUT4 being the main isoform in
muscle modulated by both insulin and
contractions (110,138). Insulin activates
GLUT4 translocation through a complex
signaling cascade (256,293). Contrac-
tions, however, trigger GLUT4 transloca-
tion at least in part through activation of
5-AMP–activated protein kinase
(198,293). Insulin-stimulated GLUT4
translocationisgenerallyimpairedintype
2 diabetes (96). Both aerobic and resis-
tance exercises increase GLUT4 abun-
dance and BG uptake, even in the presence
of type 2 diabetes (39,51,204,270).
Evidence statement. Insulin-stimulated
BG uptake into skeletal muscle predomi-
nates at rest and is impaired in type 2
diabetes, while muscular contractions
stimulate BG transport via a separate ad-
ditivemechanismnotimpairedbyinsulin
resistance or type 2 diabetes. ACSM evi-
dence category A.
Postexercise glycemic control/BG
levels
Aerobic exercise effects. During mod-
erate-intensity exercise in nondiabetic
persons,theriseinperipheralglucoseup-
takeismatchedbyanequalriseinhepatic
glucose production, the result being that
BG does not change except during pro-
longed, glycogen-depleting exercise. In
individuals with type 2 diabetes perform-
ing moderate exercise, BG utilization by
muscles usually rises more than hepatic
glucoseproduction,andBGlevelstendto
decline (191). Plasma insulin levels nor-
mally fall, however, making the risk of
exercise-induced hypoglycemia in any-
one not taking insulin or insulin secreta-
gogues very minimal, even with
prolonged PA (152). The effects of a sin-
gle bout of aerobic exercise on insulin ac-
tion vary with duration, intensity, and
subsequent diet; a single session in-
creases insulin action and glucose toler-
ance for more than 24 h but less than
72 h (26,33,85,141). The effects of
moderate aerobic exercise are similar
whether the PA is performed in a single
session or multiple bouts with the same
total duration (14).
Duringbrief,intenseaerobicexercise,
plasma catecholamine levels rise mark-
edly, driving a major increase in glucose
production (184). Hyperglycemia can re-
sult from such activity and persist for up
to 1–2 h, likely because plasma catechol-
amine levels and glucose production do
not return to normal immediately with
cessation of the activity (184).
Evidence statement. Although moderate
aerobic exercise improves BG and insulin ac-
tion acutely, the risk of exercise-induced hy-
poglycemia is minimal without use of
exogenous insulin or insulin secretagogues.
Transient hyperglycemia can follow intense
PA. ACSM evidence category C.
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effects of a single bout of resistance train-
ing on BG levels and/or insulin action in
individuals with type 2 diabetes have not
been reported. In individuals with IFG
(BG levels of 100–125 mg/dl), resistance
exercise results in lower fasting BG levels
24 h after exercise, with greater reduc-
tions in response to both volume (multi-
ple- vs. single-set sessions) and intensity
ofresistanceexercise(vigorouscompared
with moderate) (18).
Evidence statement. The acute effects of
resistance exercise in type 2 diabetes have
notbeenreported,butresultinlowerfast-
ingBGlevelsforatleast24hafterexercise
in individuals with IFG. ACSM evidence
category C.
Combined aerobic and resistance and
other types of training. A combination
of aerobic and resistance training may be
more effective for BG management than
either type of exercise alone (51,238).
Any increase in muscle mass that may re-
sult from resistance training could con-
tribute to BG uptake without altering the
muscle’s intrinsic capacity to respond to
insulin, whereas aerobic exercise en-
hances its uptake via a greater insulin ac-
tion, independent of changes in muscle
mass or aerobic capacity (51). However,
all reported combination training had a
greater total duration of exercise and ca-
loric use than when each type of training
was undertaken alone (51,183,238).
Mild-intensity exercises such as tai chi
and yoga have also been investigated for
their potential to improve BG manage-
ment, with mixed results (98,117,159,
257,269,286,291). Although tai chi may
lead to short-term improvements in BG
levels, effects from long-term training
(i.e., 16 weeks) do not seem to last 72 h
after the last session (257). Some studies
have shown lower overall BG levels with
extended participation in such activities
(286,291), although others have not
(159,257). One study suggested that yo-
ga’s beneﬁts on fasting BG, lipids, oxida-
tivestressmarkers,andantioxidantstatus
are at least equivalent to more conven-
tional forms of PA (98). However, a meta-
analysis of yoga studies stated that the
limitations characterizing most studies,
such as small sample size and varying
forms of yoga, preclude drawing ﬁrm
conclusions about beneﬁts to diabetes
management (117).
Evidence statement. A combination of
aerobic and resistance exercise training
may be more effective in improving BG
control than either alone; however, more
studies are needed to determine if total
caloric expenditure, exercise duration, or
exercise mode is responsible. ACSM evi-
dence category B. Milder forms of exercise
(e.g., tai chi, yoga) have shown mixed re-
sults. ACSM evidence category C.
Table 1—Evidence categories for ACSM and evidence-grading system for clinical practice recommendations for ADA
I. ACSM evidence categories
Evidence
category Source of evidence Deﬁnition
A Randomized, controlled trials (overwhelming data) Provides a consistent pattern of ﬁndings with substantial studies
B Randomized, controlled trials (limited data) Few randomized trials exist, which are small in size, and results are inconsistent
C Nonrandomized trials, observational studies Outcomes are from uncontrolled, nonrandomized, and/or observational studies
D Panel consensus judgment Panel’s expert opinion when the evidence is insufﬁcient to place it in categories
A–C
II. ADA evidence-grading system for clinical practice recommendations
Level of
evidence Description
A Clear evidence from well-conducted, generalizable, randomized, controlled trials that are adequately powered, including the
following:
• Evidence from a well-conducted multicenter trial
• Evidence from a meta-analysis that incorporated quality ratings in the analysis
Compelling nonexperimental evidence, i.e., the “all-or-none” rule developed by the Centre for Evidence-Based Medicine at
Oxford
Supportive evidence from well-conducted, randomized, controlled trials that are adequately powered, including the following:
• Evidence from a well-conducted trial at one or more institutions
• Evidence from a meta-analysis that incorporated quality ratings in the analysis
B Supportive evidence from well-conducted cohort studies, including the following:
• Evidence from a well-conducted prospective cohort study or registry
• Evidence from a well-conducted meta-analysis of cohort studies
Supportive evidence from a well-conducted case-control study
C Supportive evidence from poorly controlled or uncontrolled studies, including the following:
• Evidence from randomized clinical trials with one or more major or three or more minor methodological ﬂaws that could
invalidate the results
• Evidence from observational studies with high potential for bias (such as case series with comparison to historical controls)
• Evidence from case series or case reports
Conﬂicting evidence with the weight of evidence supporting the recommendation
E Expert consensus or clinical experience
Colberg and Associates
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ACSM evidence and ADA clinical practice recommendation statements
ACSM evidence category
(A, highest; D, lowest)/
ADA level of evidence
(A, highest; E, lowest)
Acute effects of exercise • PA causes increased glucose uptake into active muscles balanced by hepatic glucose
production, with a greater reliance on carbohydrate to fuel muscular activity as intensity
increases.
A/*
• Insulin-stimulated BG uptake into skeletal muscle predominates at rest and is impaired
in type 2 diabetes, while muscular contractions stimulate BG transport via a separate,
additive mechanism not impaired by insulin resistance or type 2 diabetes.
A/*
• Although moderate aerobic exercise improves BG and insulin action acutely, the risk of
exercise-induced hypoglycemia is minimal without use of exogenous insulin or insulin
secretagogues. Transient hyperglycemia can follow intense PA.
C/*
• The acute effects of resistance exercise in type 2 diabetes have not been reported, but
result in lower fasting BG levels for at least 24 h postexercise in individuals with IFG.
C/*
• A combination of aerobic and resistance exercise training may be more effective in
improving BG control than either alone; however, more studies are needed to
determine whether total caloric expenditure, exercise duration, or exercise mode is
responsible.
B/*
• Milder forms of exercise (e.g., tai chi, yoga) have shown mixed results. C/*
• PA can result in acute improvements in systemic insulin action lasting from 2 to 72 h. A/*
Chronic effects of
exercise training
• Both aerobic and resistance training improve insulin action, BG control, and fat
oxidation and storage in muscle.
B/*
• Resistance exercise enhances skeletal muscle mass. A/*
• Blood lipid responses to training are mixed but may result in a small reduction in LDL
cholesterol with no change in HDL cholesterol or triglycerides. Combined weight loss
and PA may be more effective than aerobic exercise training alone on lipids.
C/*
• Aerobic training may slightly reduce systolic BP, but reductions in diastolic BP are less
common, in individuals with type 2 diabetes.
C/*
• Observational studies suggest that greater PA and ﬁtness are associated with a lower
risk of all-cause and CV mortality.
C/*
• Recommended levels of PA may help produce weight loss. However, up to 60 min/day
may be required when relying on exercise alone for weight loss.
C/*
• Individuals with type 2 diabetes engaged in supervised training exhibit greater
compliance and BG control than those undertaking exercise training without
supervision.
B/*
• Increased PA and physical ﬁtness can reduce symptoms of depression and improve
health-related QOL in those with type 2 diabetes.
B/*
PA and prevention of
type 2 diabetes
• At least 2.5 h/week of moderate to vigorous PA should be undertaken as part of
lifestyle changes to prevent type 2 diabetes onset in high-risk adults.
A/A
PA in prevention and
control of GDM
• Epidemiological studies suggest that higher levels of PA may reduce risk of developing
GDM during pregnancy.
C/*
• RCTs suggest that moderate exercise may lower maternal BG levels in GDM. B/*
Preexercise evaluation • Before undertaking exercise more intense than brisk walking, sedentary persons with
type 2 diabetes will likely beneﬁt from an evaluation by a physician. ECG exercise
stress testing for asymptomatic individuals at low risk of CAD is not recommended but
may be indicated for higher risk.
C/C
Recommended PA
participation for
persons with type 2
diabetes
• Persons with type 2 diabetes should undertake at least 150 min/week of moderate to
vigorous aerobic exercise spread out during at least 3 days during the week, with no
more than 2 consecutive days between bouts of aerobic activity.
B/B
• In addition to aerobic training, persons with type 2 diabetes should undertake
moderate to vigorous resistance training at least 2–3 days/week.
B/B
• Supervised and combined aerobic and resistance training may confer additional health
beneﬁts, although milder forms of PA (such as yoga) have shown mixed results.
Persons with type 2 diabetes are encouraged to increase their total daily unstructured
PA. Flexibility training may be included but should not be undertaken in place of
other recommended types of PA.
B/C
(continued)
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Acute changes in muscular insulin re-
sistance. Most beneﬁts of PA on type 2
diabetes management and prevention are
realized through acute and chronic im-
provements in insulin action (29,46,
116,118,282). The acute effects of a re-
cent bout of exercise account for most of
the improvements in insulin action, with
most individuals experiencing a decrease
in their BG levels during mild- and mod-
erate-intensity exercise and for 2–72 h af-
terward (24,83,204).
BGreductionsarerelatedtothedura-
tion and intensity of the exercise, preex-
ercise control, and state of physical
training (24,26,47,238). Although previ-
ousPAofanyintensitygenerallyexertsits
effectsbyenhancinguptakeofBGforgly-
cogen synthesis (40,83) and by stimulat-
ing fat oxidation and storage in muscle
(21,64,95),moreprolongedorintensePA
acutely enhances insulin action for longer
periods (9,29,75,111,160,238).
Acute improvements in insulin sensi-
tivity in women with type 2 diabetes have
been found for equivalent energy expen-
ditureswhetherengaginginlow-intensity
orhigh-intensitywalking(29)butmaybe
affected by age and training status
(24,75,100,101,228).Forexample,mod-
erate- to heavy-intensity aerobic training
undertaken three times a week for 6
months improved insulin action in both
younger and older women but persisted
only in the younger group for 72–120 h.
Acute changes in liver’s ability to pro-
cess glucose. Increases in liver fat con-
tentcommoninobesityandtype2diabetes
are strongly associated with reduced he-
patic and peripheral insulin action. En-
hanced whole-body insulin action after
aerobictrainingseemstoberelatedtogains
in peripheral, not hepatic, insulin action
(146,282). Such training not resulting in
overall weight loss may still reduce hepatic
lipid content and alter fat partitioning and
use in the liver (128).
Evidence statement. PA can result in
acute improvements in systemic insulin
action lasting from 2 to 72 h. ACSM evi-
dence category A.
CHRONIC EFFECTS OF
EXERCISE TRAINING
Metabolic control: BG levels and insu-
linresistance. Aerobicexercisehasbeen
the mode traditionally prescribed for dia-
betes prevention and management. Even
1 week of aerobic training can improve
whole-body insulin sensitivity in individ-
uals with type 2 diabetes (282). Moderate
andvigorousaerobictrainingimprovein-
Table 2—Continued
ACSM evidence and ADA clinical practice recommendation statements
ACSM evidence category
(A, highest; D, lowest)/
ADA level of evidence
(A, highest; E, lowest)
Exercise with
nonoptimal BG
control
• Individuals with type 2 diabetes may engage in PA, using caution when exercising with
BG levels exceeding 300 mg/dl (16.7 mmol/l) without ketosis, provided they are
feeling well and are adequately hydrated.
C/E
• Persons with type 2 diabetes not using insulin or insulin secretagogues are unlikely to
experience hypoglycemia related to PA. Users of insulin and insulin secretagogues are
advised to supplement with carbohydrate as needed to prevent hypoglycemia during
and after exercise.
C/C
Medication effects on
exercise responses
• Medication dosage adjustments to prevent exercise-associated hypoglycemia may be
required by individuals using insulin or certain insulin secretagogues. Most other
medications prescribed for concomitant health problems do not affect exercise, with
the exception of -blockers, some diuretics, and statins.
C/C
Exercise with long-term
complications of
diabetes
• Known CVD is not an absolute contraindication to exercise. Individuals with angina
classiﬁed as moderate or high risk should likely begin exercise in a supervised cardiac
rehabilitation program. PA is advised for anyone with PAD.
C/C
• Individuals with peripheral neuropathy and without acute ulceration may participate
in moderate weight-bearing exercise. Comprehensive foot care including daily
inspection of feet and use of proper footwear is recommended for prevention and early
detection of sores or ulcers. Moderate walking likely does not increase risk of foot
ulcers or reulceration with peripheral neuropathy.
B/B
• Individuals with CAN should be screened and receive physician approval and possibly
an exercise stress test before exercise initiation. Exercise intensity is best prescribed
using the HR reserve method with direct measurement of maximal HR.
C/C
• Individuals with uncontrolled proliferative retinopathy should avoid activities that
greatly increase intraocular pressure and hemorrhage risk.
D/E
• Exercise training increases physical function and QOL in individuals with kidney
disease and may even be undertaken during dialysis sessions. The presence of
microalbuminuria per se does not necessitate exercise restrictions.
C/C
Adoption and
maintenance of
exercise by persons
with diabetes
• Efforts to promote PA should focus on developing self-efﬁcacy and fostering social
support from family, friends, and health care providers. Encouraging mild or moderate
PA may be most beneﬁcial to adoption and maintenance of regular PA participation.
Lifestyle interventions may have some efﬁcacy in promoting PA behavior.
B/B
*No recommendation given.
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onlyaperiodofhourstodays(141),buta
lesser intensity may also improve insulin
actiontosomedegree(111).Trainingcan
enhance the responsiveness of skeletal
muscles to insulin with increased expres-
sion and/or activity of proteins involved
in glucose metabolism and insulin signal-
ing (39,110,204,270). Moderate training
may increase glycogen synthase activity
and GLUT4 protein expression but not
insulin signaling (39). Fat oxidation is
also a key aspect of improved insulin ac-
tion, and training increases lipid storage
in muscle and fat oxidation capacity
(64,95,136,223).
An individual’s training status will af-
fecttheuseofcarbohydrateduringanaer-
obic activity. Aerobic training increases
fat utilization during a similar duration
bout of low- or moderate-intensity activ-
ity done after training, which spares mus-
cleglycogenandBGandresultsinalesser
acute decrease in BG (28,83,223). Type 2
diabetes may be associated with a de-
crease in lipid oxidation and shift toward
greatercarbohydrateoxidationatallexer-
cise intensities (87).
Resistance exercise training also ben-
eﬁts BG control and insulin action in type
2 diabetes (46,65,115,116,118,246). In a
randomizedcontrolledtrial(RCT),twice-
weekly progressive resistance training for
16 weeks by older men with newly diag-
nosed type 2 diabetes resulted in a 46.3%
increase in insulin action, a 7.1% reduc-
tion in fasting BG levels, and signiﬁcant
loss of visceral fat (116). An increase in
muscle mass from resistance training may
contribute to BG uptake from a mass ef-
fect, and heavy weight training in partic-
ularmayreverseorpreventfurtherlossof
skeletal muscle due to disuse and aging
(34,276). In another RCT, all 20 men
with type 2 diabetes who participated in
eitherresistanceoraerobicexercisethrice
weeklyfor10weeksimprovedtheirover-
all BG control, but those doing resistance
training had signiﬁcantly lower A1C val-
ues (32). Diabetic women undergoing 12
weeksoflow-intensitytrainingwithresis-
tance bands had gains in strength and
muscle mass and loss of fat mass but had
no change in insulin sensitivity (157).
Evidence statement. Both aerobic and
resistance training improve insulin ac-
tion, BG control, and fat oxidation and
storageinmuscle.ACSMevidencecategory
B. Resistance exercise enhances skeletal
muscle mass. ACSM evidence category A.
Lipids and lipoproteins. Small RCTs
involving type 2 diabetes have reported
that aerobic training decreases total and
LDL cholesterol and raises HDL choles-
terol (130,229). One larger RCT found
decreases in total cholesterol with both
aerobic and yoga training but no changes
in HDL cholesterol or LDL cholesterol
(98), although most have found no effect
of any form of exercise training on lipids
(6,175,178,238,258,267). RCTs de-
signedtoincreasePAalsohadnoeffecton
the cholesterol proﬁle in type 2 diabetes,
with most also ﬁnding no change in trig-
lycerides (6,175,238,258,267). A meta-
analysis of training effects on blood lipids
inadultswithtype2diabetesfound,how-
ever,thatLDLcholesterolmaybereduced
by 5% (136).
Lipid proﬁles may beneﬁt more from
concomitant exercise training and weight
reduction. Some studies using intensive
dietandaerobicexerciseinterventionsre-
ported large reductions in total choles-
terol and triglycerides but failed to
include controls (12,13). In the Look
AHEAD (Action for Health in Diabetes)
study, intensive lifestyle participants ex-
hibited greater decreases in triglycerides
andincreasesinHDLcholesterolthanthe
control group, while both the intensive
lifestyle and usual care groups decreased
LDL cholesterol (218). Most lifestyle in-
terventionshavebeenaccompaniedbyan
approximate 5-kg weight loss.
Evidence statement. Blood lipid re-
sponsestotrainingaremixedbutmayresult
inasmallreductioninLDLcholesterolwith
no change in HDL cholesterol or triglycer-
ides. Combined weight loss and PA may be
moreeffectivethanaerobicexercisetraining
alone on lipids. ACSM evidence category C.
Hypertension. Hypertension is a com-
mon comorbidity affecting more than
60% of individuals with type 2 diabetes
(201,249). The risk of vascular complica-
tions in hypertensive individuals with
type 2 diabetes is 66–100% higher than
with either condition alone (103,195).
Both aerobic and resistance training can
lower BP in nondiabetic individuals, with
slightly greater effects observed with the
former (49,134,135,137). Most observa-
tional studies show that both exercises
lower BP in diabetic individuals (35,
46,78,208,267). Several RCTs have
shown reductions in systolic BP (4–8
mmHg), but only one reported a slightly
lower diastolic BP (11,130,140,176). The
Look AHEAD trial found reductions in
both systolic and diastolic BP with exer-
cise and weight loss (218), but several
studies have reported no changes in BP
with training in type 2 diabetes
(175,238,283). Carefully designed RCTs
using increasing levels of PA also failed to
show any change in BP despite substan-
tially increased PA (6,258).
Evidence statement. Aerobic training
may slightly reduce systolic BP, but re-
ductions in diastolic BP are less common,
inindividualswithtype2diabetes.ACSM
evidence category C.
Mortality and CV risk. Higher levels of
physical ﬁtness and PA are associated
with lower CV risk and mortality in both
healthy and clinical populations (19,
153,164,207). Increases in PA and phys-
ical ﬁtness are also associated with re-
ducedearlymortalityinbothpopulations
as well (19,42,153,163,164,186,272).
All-cause and CV mortality risk was 1.7–
6.6timeshigherinlow-ﬁtcomparedwith
high-ﬁt men with type 2 diabetes, with
the ﬁttest men exhibiting the lowest risk
(42,43). A work capacity 10 METs
(where1METisdeﬁnedastheequivalent
of resting metabolic rate) carries the low-
est risk, independent of obesity
(42,153,186). No RCT data on the effects
ofchangesinphysicalﬁtnessonmortality
in diabetes exist.
Evidence statement. Observational
studies suggest that greater PA and ﬁtness
are associated with a lower risk of all-
cause and CV mortality. ACSM evidence
category C.
Body weight: maintenance and loss.
The most successful programs for long-
term weight control have involved com-
binations of diet, exercise, and behavior
modiﬁcation (281). Exercise interven-
tions undertaken with volumes typically
recommendedtoimproveBGcontroland
reduce CVD risk (e.g., 150 min/week of
brisk walking) are usually insufﬁcient for
major weight loss (24), likely because
obese and older people frequently have
difﬁcultyperformingsufﬁcientexerciseto
create a large energy deﬁcit and can easily
counterbalance expenditures by eating
more (281). However, in RCTs, about 1 h
of daily moderate aerobic exercise pro-
duces at least as much fat loss as equiva-
lent caloric restriction, with resultant
greater insulin action (231,232).
The optimal volume of exercise to
achieve sustained major weight loss is
probably much larger than the amount
required to achieve improved BG control
and CV health (24,217). In observational
studies (234,235,274), individuals who
successfully maintained large weight loss
during at least a year typically engaged in
7 h/week of moderate- to vigorous-
intensity exercise (62). Two RCTs found
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2,500 kcal/week) produced greater and
more sustained weight loss than 1,000
kcal/week of exercise (123,124).
Evidence statement. Recommended lev-
els of PA may help produce weight loss.
However, up to 60 min/day may be re-
quired when relying on exercise alone for
weight loss. ACSM evidence category C.
Supervision of training. Exercise inter-
vention studies showing the greatest ef-
fect on BG control have all involved
supervision of exercise sessions by quali-
ﬁed exercise trainers (34,65,196,238).
The most direct test of the incremental
beneﬁts of supervised training was the
Italian Diabetes and Exercise Study (11).
In this 1-year trial, all 606 participants with
type 2 diabetes (both intervention and con-
trol)receivedhigh-qualityexercisecounsel-
ing that increased self-reported PA
substantially. The intervention group also
received supervised, facility-based com-
bined aerobic and resistance exercise
training twice weekly, resulting in greater
improvements in overall BG control, BP,
BMI, waist circumference, HDL choles-
terol, and estimated 10-year CVD risk. A
recent systematic review of 20 resistance
training studies on type 2 diabetes (97)
found that supervised training of varying
volume, frequency, and intensity im-
provedBGcontrolandinsulinsensitivity,
but that when supervision was removed,
compliance and BG control both
deteriorated.
Evidence statement. Individuals with
type 2 diabetes engaged in supervised
training exhibit greater compliance and
BG control than those undertaking exer-
cise training without supervision. ACSM
evidence category B.
Psychological effects. Exercise likely
has psychological beneﬁts for persons
with type 2 diabetes, although evidence
for acute and chronic psychological ben-
eﬁts is limited. In the Look AHEAD trial,
participantsintheintensivelifestyleinter-
vention attempted to lose more than 7%
of their initial weight and increase mod-
erately intense PA to greater than 175
min/week. They had improvements in
health-related (SF-36 physical compo-
nent scores) quality of life (QOL) and de-
pression symptoms after 12 months that
were mediated by enhanced physical ﬁt-
ness (280).
However, it seems that individuals
who undertake exercise to prevent a
chronicdiseasefarebetterthanthosewho
undertake it to manage an existing one. A
recent meta-analysis found that while
psychological well-being was signiﬁ-
cantly improved among individuals who
exercised for disease prevention, it dete-
riorated signiﬁcantly when undertaken
for management of CVD, end-stage renal
disease, pulmonary disease, neurological
disorders, and cancer (90). These ﬁnd-
ings suggest that beneﬁts may vary, with
those with fewer existing complications
beneﬁting the most.
Meta-analyses of clinically depressed
men and women of all age-groups found
substantial decreases in depressive symp-
toms after both short and long courses of
exercise (50) and clinical depression and
depressive symptoms among the aged
(243). Potential mechanisms of exercise
include psychological factors, such as in-
creased self-efﬁcacy, a sense of mastery,
distraction, and changes in self-concept,
as well as physiological factors such as in-
creased central norepinephrine transmis-
sion, changes in the hypothalamic
adrenocortical system (63), serotonin
synthesis and metabolism (61), and en-
dorphins. Regular PA may improve psy-
chological well-being, health-related
QOL, and depression in individuals with
type 2 diabetes, among whom depression
is more common than in the general pop-
ulation (73).
Evidence statement. Increased PA and
physical ﬁtness can reduce symptoms of
depression and improve health-related
QOL in those with type 2 diabetes. ACSM
evidence category B.
PA AND PREVENTION OF
TYPE 2 DIABETES— Participation
in regular PA improves BG control and
can prevent or delay onset of type 2 dia-
betes (64,104,149,158, 170,260). Pro-
spective cohort and cross-sectional
observational studies that assessed PA
with questionnaires showed that higher
PA levels are associated with reduced risk
for type 2 diabetes, regardless of method
of activity assessment, ranges of activity
categories, and statistical methods
(108,113,182). Both moderate walking
and vigorous activity have been associ-
ated with a decreased risk, and greater
volumes of PA may provide the most pre-
vention(113).Observationalstudieshave
reported that greater ﬁtness is associated
with a reduced risk of developing type 2
diabetes (251,273), even if only moder-
ate-intensity exercise is undertaken.
The Da Qing study in China (211)
included an exercise-only treatment arm
andreportedthatevenmodestchangesin
exercise (20 min of mild or moderate, 10
min of strenuous, or 5 min of very stren-
uous exercise one to two times a day) re-
duced diabetes risk by 46% (compared
with 42% for diet plus exercise and 31%
for diet alone). The Finnish Diabetes Pre-
vention Study (74,260) and the U.S. Dia-
betes Prevention Program (DPP) (149)
includedintensive,lifestylemodiﬁcations
with both diet and increased PA. In the
former, 522 middle-aged, overweight
adults with IGT completed either lifestyle
modiﬁcations of at least 30 min of daily,
moderate PA, or no change in behavior
(74,260). The DPP randomized 3,234
men and women with IGT or IFG into
control, medication (metformin), or life-
style modiﬁcation groups, composed of
dietaryandweightlossgoalsand150min
of weekly aerobic activity (149). Lifestyle
modiﬁcation in both studies reduced in-
cident diabetes by 58% and, in the DPP,
had a greater effect than metformin
(31%). Weight loss was the dominant
predictor of a lower incidence, but in-
creasedPAreducedriskoftype2diabetes
even when weight loss goals were not
achieved (104,158,173). PA seems to
play a role in preventing type 2 diabetes
across ethnic groups and in both sexes
(154,224).
Data show that moderate exercise
such as brisk walking reduces risk of type
2 diabetes (108,113,114,154,224), and
all studies support the current recom-
mendation of 2.5 h/week of a moderate
aerobic activity or typically 30 min/day
for 5 days/week for prevention. A meta-
analysis of 10 cohort studies (125) that
assessed the preventive effects of moder-
ate-intensity PA found that risk reduction
for type 2 diabetes was 0.70 (0.58–0.84)
for walking on a regular basis (typically
briskly for 2.5 h/week). The preventive
effectsofresistancetraininghavenotbeen
studied.
Type 2 diabetes is also increasing in
prevalence in children and adolescents,
with increasingly sedentary behavior and
obesity as key contributors. No RCTs
have been completed that address
whether PA or exercise prevents type 2
diabetes in youth. However, limited stud-
ies suggest that, to prevent and manage
type 2 diabetes, goals for youth should
include limiting daily screen time (televi-
sion, computer, or video game) to less
than 60 min/day and doing at least 60
min/day of PA (188). A multicenter trial
(theTODAYstudy)iscurrentlyunderway
to assess the role of PA as part of a behav-
ioral lifestyle intervention aimed at pre-
venting type 2 diabetes in youth (254).
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of moderate to vigorous PA should be un-
dertaken as part of lifestyle changes to
prevent type 2 diabetes onset in high-risk
adults. ACSM evidence category A. ADA A
level recommendation.
PA AND PREVENTION AND
CONTROL OF GDM— As the prev-
alenceofdiabetescontinuestoriseworldwide,
it becomes increasingly important to identify
high-riskpopulationsandtoimplementstrat-
egies to delay or prevent diabetes onset.
WomendiagnosedwithGDMareatsubstan-
tially increased risk of developing type 2 dia-
betes; therefore, PA may be considered a tool
to prevent both GDM and possibly type 2 di-
abetes at a later date (70). Prepregnancy PA
has been consistently associated with a re-
duced risk of GDM (57,58,69,206, 290).
Studies during pregnancy are sparse, with
only one case-control study (57), one retro-
spective study (174), and one study of a co-
hort of Hispanic women (37) observing
signiﬁcant protective effects of PA, while oth-
ers have not (58,69,206).
Engaging in 30 min of moderate-
intensity PA (e.g., brisk walking) during
most days of the week (e.g., 2.5 h/week)
has been adopted as a recommendation
for pregnant women without medical or
obstetrical complications (222). How-
ever,fewprimarypreventionstudieshave
examinedwhethermakingachangeinPA
reducesriskofdevelopingGDM.In2006,
a meta-analysis reviewed four RCTs on
GDM in which pregnant women in their
thirdtrimesterexercisedonacycleorarm
ergometer or performed resistance train-
ing three times a week for 20–45 min
comparedwithdoingnospeciﬁcprogram
(36).Thewomeninvolvedinexercisehad
better BG control, lower fasting and post-
prandial glucose concentrations, and im-
proved cardiorespiratory ﬁtness,
although frequency of prescription of in-
sulin to control BG did not differ from
nonexercisers, and pregnancy outcomes
were unchanged.
Evidence statement. Epidemiological
studies suggest that higher levels of PA
may reduce risk of developing GDM dur-
ing pregnancy. ACSM evidence category C.
RCTs suggest that moderate exercise may
lower maternal BG levels in GDM. ACSM
evidence category B.
PREEXERCISE EVALUATION—
Safe exercise participation can be compli-
cated by the presence of diabetes-related
healthcomplicationssuchasCVD,hyper-
tension, neuropathy, or microvascular
changes(239).Forindividualsdesiringto
participate in low-intensity PA such as
walking,healthcareprovidersshoulduse
clinical judgment in deciding whether to
recommend preexercise testing (3). Con-
ducting exercise stress testing before
walking is unnecessary. No evidence sug-
gests that it is routinely necessary as a
CVDdiagnostictool,andrequiringitmay
create barriers to participation.
Forexercisemorevigorousthanbrisk
walking or exceeding the demands of ev-
eryday living, sedentary and older dia-
betic individuals will likely beneﬁt from
being assessed for conditions that might
be associated with risk of CVD, contrain-
dicate certain activities, or predispose to
injuries, including severe peripheral neu-
ropathy, severe autonomic neuropathy,
and preproliferative or proliferative reti-
nopathy (240). Before undertaking new
higher-intensity PA, they are advised to
undergo a detailed medical evaluation
and screening for BG control, physical
limitations, medications, and macrovascu-
lar and microvascular complications (3).
Thisassessmentmayincludeagraded
exercise test depending on the age of the
person, diabetes duration, and the pres-
ence of additional CVD risk factors
(3,240). The prevalence of symptomatic
and asymptomatic coronary artery dis-
ease (CAD) is greater in individuals with
type 2 diabetes (72,155), and maximal
graded exercise testing can identify a
small proportion of asymptomatic per-
sons with severe coronary artery obstruc-
tion (52).
Most young individuals with a low
CAD risk may not beneﬁt from preexer-
cise stress testing. In the Look AHEAD
trial, although exercise-induced abnor-
malities were present in 1,303 (22.5%)
participants, only older age was associ-
ated with increased prevalence of all ab-
normalities during maximal testing (52).
AsystematicreviewoftheU.S.Preventive
Services Task Force (USPSTF) concluded
that stress testing should not be routinely
recommended to detect ischemia in
asymptomatic individuals with a low
CAD risk (10% risk of a cardiac event
more than 10 years) because the risks
from invasive testing done after a false-
positive test outweigh the beneﬁts of its
detection (79,262). The lower the CAD
risk, the higher the chance of a false pos-
itive (79,248).
Current guidelines attempt to avoid
automaticinclusionoflower-riskindivid-
uals with type 2 diabetes, stating that ex-
ercise stress testing is advised primarily
for previously sedentary individuals with
diabetes who want to undertake activity
moreintensethanbriskwalking.Thegoal
is to more effectively target individuals at
higher risk for underlying CVD (239).
The UKPDS Risk Engine (http://www.
dtu.ox. ac.uk/riskengine/download.htm)
(248) can also be used to calculate ex-
pected 10-year CV risk based on age, sex,
smoking, A1C, diabetes duration, lipids,
BP, and race.
In general, electrocardiogram (ECG)
stress testing may be indicated for indi-
viduals matching one or more of these
criteria:
● Age 40 years, with or without CVD
risk factors other than diabetes
● Age 30 years and
● Type 1 or type 2 diabetes of 10
years in duration
● Hypertension
● Cigarette smoking
● Dyslipidemia
● Proliferative or preproliferative reti-
nopathy
● Nephropathy including microalbu-
minuria
● Any of the following, regardless of age
● Known or suspected CAD, cerebro-
vascular disease, and/or peripheral
artery disease (PAD)
● Autonomic neuropathy
● Advanced nephropathy with renal
failure
Use of these criteria does not exclude
the possibility of conducting ECG stress
testingonindividualswithalowCADrisk
or those who planning to engage in less
intense exercise (248). In the absence of
contraindications to maximal stress test-
ing, it can still be considered for anyone
withtype2diabetes.Althoughclinicalev-
idence does not deﬁnitively determine
who should undergo such testing, poten-
tialbeneﬁtsshouldbeweighedagainstthe
risk associated with unnecessary proce-
dures for each individual (155,239).
In individuals with positive or non-
speciﬁc ECG changes in response to exer-
cise, or with nonspeciﬁc ST- and T-wave
changes at rest, follow-up testing may be
performed (236). However, the DIAD
trial involving 1,123 individuals with
type 2 diabetes and no symptoms of CAD
found that screening with adenosine-
stress radionuclide myocardial perfusion
imaging for myocardial ischemia more
than4.8yearsdidnotalterratesofcardiac
events (288); thus, the cost-effectiveness
and diagnostic value of more intensive
testing remains in question.
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termine whether preexercise evaluation
involving stress testing is necessary or
beneﬁcial before participation in anaero-
bicorresistancetraining.Atpresent,most
testing centers are equipped for maximal
stress testing but not for an alternate form
of testing involving resistance exercise.
Moreover, coronary ischemia is less likely
tooccurduringresistancecomparedwith
aerobic exercise eliciting the same heart
rate (HR), and some doubt exists as to
whether resistance exercise induces isch-
emia (77,88). A review of 12 studies of
resistance exercise in men with known
CAD found no angina, ST depression, ab-
normal hemodynamics, ventricular dys-
rhythmias, or other complications during
such exercise (275).
Evidence statement. Before undertaking
exercise more intense than brisk walking,
sedentary persons with type 2 diabetes
will likely beneﬁt from an evaluation by a
physician. ECG exercise stress testing for
asymptomatic individuals at low risk of
CAD is not recommended but may be in-
dicatedforhigherrisk.ACSMevidencecat-
egory C. ADA C level recom-
mendation.
RECOMMENDED PA
PARTICIPATION FOR
PERSONS WITH TYPE 2
DIABETES— Just 39% of adults with
diabetes are physically active compared
with58%ofotherAmericanadults(193).
However, for most people with type 2 di-
abetes, exercise is recommended for dia-
betes management and can be
undertaken safely and effectively.
Aerobic exercise training
Frequency. Aerobic exercise should be
performed at least 3 days/week with no
more than 2 consecutive days between
bouts of activity because of the transient
natureofexercise-inducedimprovements
in insulin action (26,141). Most clinical
trials evaluating exercise interventions in
type 2 diabetes have used a frequency of
three times per week (24,238,246,255),
butcurrentguidelinesforadultsgenerally
recommend ﬁve sessions of moderate ac-
tivity (105,202,217).
Intensity. Aerobic exercise should be at
least at moderate intensity, correspond-
ing approximately to 40–60% of VO2max
(maximal aerobic capacity). For most
peoplewithtype2diabetes,briskwalking
is a moderate-intensity exercise. Addi-
tional beneﬁts may be gained from vigor-
ous exercise (60% of VO2max). A meta-
analysis (25) showed that exercise
intensity predicts improvements in over-
all BG control to a greater extent than ex-
ercise volume, suggesting that those
already exercising at a moderate intensity
should consider undertaking some vigor-
ousPAtoobtainadditionalBG(andlikely
CV) beneﬁts.
Duration. Individualswithtype2diabe-
tes should engage in a minimum of 150
min/week of exercise undertaken at mod-
erate intensity or greater. Aerobic activity
should be performed in bouts of at least
10 min and be spread throughout the
week. Around 150 min/week of moder-
ate-intensity exercise is associated with
reduced morbidity and mortality in ob-
servational studies in all populations
(217). The average weekly duration in
meta-analyses of exercise interventions in
type 2 diabetes (24,246,255), including
higher-intensity aerobic exercise (196),
has been in a similar range. Recent joint
ACSM/American Heart Association
guidelines (105,202) recommended 150
min of moderate activity (30 min, 5 days/
week) or 60 min of vigorous PA (20 min
on 3 days) for all adults, whereas recent
U.S. federal guidelines (217) recom-
mended 150 min of moderate or 75 min
ofvigorousactivity,oranequivalentcom-
bination, spread throughout each week.
TheU.S.federalguidelines(217)sug-
gest that an exercise volume of 500–
1,000 MET   min/week (MET equivalent
of PA  number of minutes) is optimal
and can be achieved, for example, with
150 min/week of walking at 6.4 km/h (4
mph; intensity of 5 METs) or 75 min of
jogging at 9.6 km/h (6 mph; 10 METs).
Unfortunately, most people with type 2
diabetesdonothavesufﬁcientaerobicca-
pacity to jog at 9.6 km/h for that weekly
duration, and they may have orthopedic
or other limitations. In a meta-analysis,
the mean maximal aerobic capacity in di-
abetic individuals was only 22.4 ml/kg/
min, or 6.4 METs (25), making 4.8 METs
(75% of maximal) the highest sustainable
intensity. Therefore, most diabetic indi-
viduals will require at least 150 min of
moderate to vigorous aerobic exercise per
week to achieve optimal CVD risk reduc-
tion. Some CV and BG beneﬁts may be
gained from lower exercise volumes (a
minimum dose has not been established),
whereasfurtherbeneﬁtlikelyresultsfrom
engaging in durations beyond recom-
mended amounts. Individuals with
higher aerobic capacities (10 METs)
may be able to exercise at a higher abso-
luteintensityforlesstimeandachievethe
same beneﬁts.
Mode. Any form of aerobic exercise (in-
cluding brisk walking) that uses large
muscle groups and causes sustained in-
creases in HR is likely to be beneﬁcial
(114),andundertakingavarietyofmodes
of PA is recommended (217).
Rate of progression. At present, no
study on individuals with type 2 diabetes
has compared rates of progression in ex-
ercise intensity or volume. Gradual pro-
gression of both is advisable to minimize
the risk of injury, particularly if health
complications are present, and to en-
hance compliance.
Body weight loss and maintenance.
The most successful weight control pro-
grams involve combinations of exercise,
diet, and behavior modiﬁcation. People
who successfully maintain a large weight
loss report exercising about 7 h/week
(62,212,234,235,274).
Evidence statement. Persons with type 2
diabetes should undertake at least 150
min/week of moderate to vigorous aero-
bic exercise spread out during at least 3
days during the week, with no more than
2 consecutive days between bouts of aer-
obic activity. ACSM evidence category B.
ADA B level recommendation.
Resistance exercise training
Frequency. Resistance exercise should
be undertaken at least twice weekly on
nonconsecutive days (1,105,202,217,
239,240), but more ideally three times a
week (65,246), as part of a PA program
forindividualswithtype2diabetes,along
with regular aerobic activities.
Intensity. Training should be moderate
(50% of 1-repetition maximum [1-RM])
or vigorous (75–80% of 1-RM) for opti-
mal gains in strength and insulin action
(1,97,239,240,263). Home-based resis-
tance training following supervised, gym-
based training may be less effective for
maintaining BG control but adequate for
maintaining muscle mass and strength
(66).
Duration. Each training session should
minimally include 5–10 exercises involv-
ingthemajormusclegroups(intheupper
body, lower body, and core) and involve
completion of 10–15 repetitions to near
fatigue per set early in training (1,
97,239,240,263), progressing over time to
heavier weights (or resistance) that can be
liftedonly8–10times.Aminimumofoneset
of repetitions to near fatigue, but as many as
threetofoursets,isrecommendedforoptimal
strength gains.
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weights (e.g., dumbbells and barbells)
can result in fairly equivalent gains in
strength and mass of targeted muscles
(66). Heavier weights or resistance may
be needed for optimization of insulin ac-
tion and BG control (276).
Rate of progression. To avoid injury,
progression of intensity, frequency, and
durationoftrainingsessionsshouldoccur
slowly. In most progressive training, in-
creases in weight or resistance are under-
taken ﬁrst and only once when the target
number of repetitions per set can consis-
tently be exceeded, followed by a greater
number of sets and lastly by increased
training frequency. Progression for 6
months to thrice-weekly sessions of three
setsof8–10repetitionsdoneat75to80%
of 1-RM on 8–10 exercises may be an op-
timal goal (65).
Evidence statement. In addition to aero-
bic training, persons with type 2 diabetes
should undertake moderate to vigorous
resistancetrainingatleast2–3days/week.
ACSM evidence category B. ADA B level
recommendation.
Supervised training
Initial instruction and periodic supervi-
sion by a qualiﬁed exercise trainer is rec-
ommended for most persons with type 2
diabetes,particularlyiftheyundertakere-
sistance exercise training, to ensure opti-
malbeneﬁtstoBGcontrol,BP,lipids,and
CV risk and to minimize injury risk (11).
Combined aerobic and resistance
and other types of training
Inclusion of both aerobic and resistance
exercise training is recommended. Com-
bined training thrice weekly in individu-
als with type 2 diabetes may be of greater
beneﬁt to BG control than either aerobic
or resistance exercise alone (238). How-
ever, the total duration of exercise and
caloric expenditure was greatest with
combined training in all studies done to
date (51,183,238), and both types of
training were undertaken together on the
same days. No studies have yet reported
whether daily, but alternating, training is
more effective or the BG effect of isoca-
loric combinations of training. Milder
formsofPA,suchasyogaandtaichi,may
beneﬁt control of BG (98,117,269,
286,291), although their inclusion is not
supported conclusively at this time.
Daily movement (unstructured
activity)
Individuals with type 2 diabetes are en-
couraged to increase their total daily, un-
structured PA to gain additional health
beneﬁts.Nonexerciseactivitythermogen-
esis (i.e., energy expending for activities
of daily living) can create a large daily ca-
loric deﬁcit to prevent excessive weight
gain (168,169). In an observational
study, obese individuals sat for about
2.5 h more and walked an average of 3.5
miles/day or less than their lean counter-
partsdo.Mostoftheleansubjects’greater
activity came from walks of short dura-
tion (15 min) and low velocity (1
mph) (168).
Moreover, use of objective measures
suchasstepcountersmayenhancereach-
ing daily goals. A meta-analysis of 26
studies with a total of 2,767 (primarily
nondiabetic) participants (8 RCTs and 18
observational studies) found that pedom-
eter users increased PA by 26.9% over
baseline in studies having an average in-
tervention of 18 weeks (30). An impor-
tant predictor of increased PA was the use
of a goal, such as to take 10,000 steps per
day (30).
Flexibility training
Flexibility training may be included as
part of a PA program, although it should
not substitute for other training. Older
adults are advised to undertake exercises
that maintain or improve balance
(202,217), which may include some ﬂex-
ibility training, particularly for many
older individuals with type 2 diabetes
with a higher risk of falling (194). Al-
though ﬂexibility exercise (stretching)
has frequently been recommended as a
means of increasing joint range of motion
(ROM) and reducing risk of injury, two
systematic reviews found that ﬂexibility
exercise does not reduce risk of exercise-
induced injury (237,287). A small RCT
found that ROM exercises modestly de-
creased peak plantar pressures (94), but
no study has directly evaluated whether
suchtrainingreducesriskofulcerationor
injury in type 2 diabetes. However, ﬂexi-
bility exercise combined with resistance
training can increase ROM in individuals
with type 2 diabetes (109) and allow in-
dividuals to more easily engage in activi-
ties that require greater ROM around
joints.
Evidence statement. Supervised and
combined aerobic and resistance training
may confer health additional beneﬁts, al-
though milder forms of PA (such as yoga)
have shown mixed results. Persons with
type2diabetesareencouragedtoincrease
theirtotaldailyunstructuredPA.Flexibil-
ity training may be included but should
not be undertaken in place of other rec-
ommended types of PA. ACSM evidence
category B. ADA C level recommendation.
EXERCISE WITH
NONOPTIMAL BG CONTROL
Hyperglycemia. While hyperglycemia
can be worsened by exercise in type 1 di-
abetic individuals who are insulin deﬁ-
cient and ketotic (due to missed or
insufﬁcient insulin), very few persons
with type 2 diabetes develop such a pro-
founddegreeofinsulindeﬁciency.There-
fore, individuals with type 2 diabetes
generally do not need to postpone exer-
cise because of high BG, provided that
they are feeling well. If they undertake
strenuousphysicalactivitieswithelevated
glucose levels (300 mg/dl or 16.7
mmol/l), it is prudent to ensure that they
are adequately hydrated (3). If hypergly-
cemicafterameal,individualswithtype2
diabetes will still likely experience a re-
duction in BG during aerobic work be-
cause endogenous insulin levels will
likely be higher at that time (221).
Evidence statement. Individuals with
type 2 diabetes may engage in PA, using
caution when exercising with BG levels
exceeding 300 mg/dl (16.7 mmol/l) with-
out ketosis, provided they are feeling well
and are adequately hydrated. ACSM
evidence category C. ADA E level
recommendation.
Hypoglycemia: causes and prevention.
Of greatest concern to many exercisers is
the risk of hypoglycemia. In individuals
whosediabetesisbeingcontrolledbylife-
style alone, the risk of developing hypo-
glycemia during exercise is minimal,
making stringent measures unnecessary
to maintain BG (239). Glucose monitor-
ing can be performed before and after PA
to assess its unique effect. Activities of
longer duration and lower intensity
generally cause a decline in BG levels but
not to the level of hypoglycemia
(9,29,75,111,160). While very intense
activities can cause transient elevations in
BG (156,252,253), intermittent high-
intensity exercise done immediately after
breakfast in individuals treated with diet
only reduces BG levels and insulin secre-
tion (160).
In insulin or insulin secretagogue us-
ers, who frequently have the effects of
both exercise and insulin to increase glu-
cose uptake, PA can complicate diabetes
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preexercise BG levels of less than 100
mg/dl (5.5 mmol/l), ADA recommends
that carbohydrate be ingested before any
PA(3),butthisappliesonlytoindividuals
taking insulin or the secretagogues more
likely to cause hypoglycemia (e.g., sulfo-
nylureas such as glyburide, glipizide, and
glimepiride, as well as nateglinide and re-
paglinide) (161,230). If controlled with
diet or other oral medications, most indi-
viduals will not need carbohydrate sup-
plements for exercise lasting less than an
hour.Insulinusersshouldlikelyconsume
upto15gofcarbohydratebeforeexercise
for an initial BG level of 100 mg/dl or
lower, with the actual amount dependent
on injected insulin doses, exercise dura-
tionandintensity,andresultsofBGmon-
itoring. Intense, short exercise requires
lesser or no carbohydrate intake (156).
Later-onset hypoglycemia is a greater
concern when carbohydrate stores (i.e.,
muscle and liver glycogen) are depleted
during an acute bout of exercise. In par-
ticular, high-intensity exercise (e.g., re-
peated interval or intense resistance
training) can result in substantial deple-
tion of muscle glycogen, thereby increas-
ing risk for postexercise hypoglycemia in
users of insulin or insulin secretagogues
(161). In such cases, the consumption of
5–30gofcarbohydrateduringandwithin
30 min after exhaustive, glycogen-
depleting exercise will lower hypoglyce-
mia risk and allow for more efﬁcient
restoration of muscle glycogen (31,247).
Evidence statement. Persons with type 2
diabetes not using insulin or insulin
secretagogues are unlikely to experience
hypoglycemia related to PA. Users of in-
sulin and insulin secretagogues are ad-
visedtosupplementwithcarbohydrateas
needed to prevent hypoglycemia during
andafterexercise.ACSMevidencecategory
C. ADA C level recommendation.
MEDICATION EFFECTS ON
EXERCISE RESPONSES — Current
treatment strategies promote combina-
tion therapies to address the three major
defects in type 2 diabetes: impaired pe-
ripheral glucose uptake (liver, fat, and
muscle),excessivehepaticglucoserelease
(with glucagon excess), and insufﬁcient
insulin secretion. Medication adjust-
ments for PA are generally necessary only
with use of insulin and other insulin
secretagogues (161,230). To prevent hy-
poglycemia, individuals may need to re-
duce their oral medications or insulin
dosingbefore(andpossiblyafter)exercise
(83,161). Before planned exercise, short-
acting insulin doses will likely have to be
reduced to prevent hypoglycemia.
Newer,synthetic,rapid-actinginsulinan-
alogs(i.e.,lispro,aspart,andglulisine)in-
duce more rapid decreases in BG than
regular human insulin. Individuals will
need to monitor BG levels before, occa-
sionally during, and after exercise and
compensate with appropriate dietary
and/or medication regimen changes, par-
ticularly when exercising at insulin peak
times. If only longer-acting insulins such
as glargine, detemir, and NPH are being
absorbed from subcutaneous depots dur-
ing PA, exercise-induced hypoglycemia is
not as likely (219), although doses may
need to be reduced to accommodate reg-
ular participation in PA. Doses of select
oral hypoglycemic agents (glyburide,
glipizide, glimepiride, nateglinide, and
repaglinide) may also need to be lowered
in response to regular exercise training if
the frequency of hypoglycemia increases
(161,230).
Diabetic individuals are often pre-
scribed a variety of medications for co-
morbid conditions, including diuretics,
-blockers,ACEinhibitors,aspirin,lipid-
lowering agents, and more. These medi-
cations generally do not affect exercise
responses, with some notable exceptions.
-Blockers are known to blunt HR re-
sponses to exercise and lower maximal
exercisecapacityto87%ofexpectedvia
negative inotropic and chronotropic
effects (241). They may also block adren-
ergic symptoms of hypoglycemia, in-
creasing the risk of undetected
hypoglycemia during exercise. However,
-blockersmayincreaseexercisecapacity
in those with CAD, rather than lowering
it, by reducing coronary ischemia during
activity (53). Diuretics, however, may
lower overall blood and ﬂuid volumes re-
sulting in dehydration and electrolyte im-
balances, particularly during exercise in
the heat. Statin use has been associated
with an elevated risk of myopathies (my-
algia and myositis), particularly when
combined with use of ﬁbrates and niacin
(203). An extended discussion on medi-
cations can be found in the Handbook of
Exercise in Diabetes (2002) (84).
Evidence statement. Medication dosage
adjustments to prevent exercise-
associatedhypoglycemiamayberequired
by individuals using insulin or certain in-
sulin secretagogues. Most other medica-
tions prescribed for concomitant health
problems do not affect exercise, with the
exception of -blockers, some diuretics,
and statins. ACSM evidence category C.
ADA C level recommendation.
EXERCISE WITH LONG-
TERM COMPLICATIONS OF
DIABETES
Vascular disease. Individuals with an-
ginaandtype2diabetesclassiﬁedasmod-
erate or high risk should preferably
exercise in a supervised cardiac rehabili-
tation program, at least initially (245).
Diabetes accelerates the development of
atherosclerosis and is a major risk factor
for CVD and PAD. Individuals with type
2 diabetes have a lifetime risk of CAD
that includes 67% of women and 78% of
men and is exacerbated by obesity
(22,80,165). Moreover, some individuals
who have an acute myocardial infarction
may not experience chest pain, and up to
a third may have silent myocardial isch-
emia (45,180).
For individuals with PAD, with and
without intermittent claudication and
pain in the extremities during PA, low-to-
moderate walking, arm-crank, and cycling
exercise have all been shown to enhance
mobility, functional capacity, exercise pain
tolerance, and QOL (214,295). Lower ex-
tremity resistance training also improves
functionalperformancemeasuredbytread-
mill walking, stair climbing ability, and
QOL measures (187).
Vascular alterations are common in
diabetes, even in the absence of overt vas-
cular disease. Endothelial dysfunction
may be an underlying cause of many as-
sociated vascular problems (45,54). In
addition to traditional risk factors, hyper-
glycemia, hyperinsulinemia, and oxida-
tive stress contribute to endothelial
damage, leading to poor arterial function
andgreatersusceptibilitytoatherogenesis
(45,82,289). Both aerobic and resistance
trainingcanimproveendothelialfunction
(46,294), but not all studies have shown
posttraining improvement (283).
Evidence statement. Known CVD is not
anabsolutecontraindicationtoexercise.In-
dividualswithanginaclassiﬁedasmoderate
orhighriskshouldlikelybeginexerciseina
supervised cardiac rehabilitation program.
PA is advised for anyone with PAD. ACSM
evidence category C. ADA C level
recommendation.
Peripheral neuropathy. Mild to moder-
ate exercise may help prevent the onset of
peripheral neuropathy (10). Individuals
without acute foot ulcers can undertake
moderate weight-bearing exercise, al-
though anyone with a foot injury or open
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weight-bearingPA.Allindividualsshould
closely examine their feet on a daily basis
to prevent and detect sores or ulcers early
and follow recommendations for use of
proper footwear. Previous guidelines
stated that persons with severe peripheral
neuropathy should avoid weight-bearing
activitiestoreduceriskoffootulcerations
(102,264). However, recent studies indi-
cated that moderate walking does not in-
creaseriskoffootulcersorreulcerationin
those with peripheral neuropathy
(166,167).
Peripheral neuropathy affects the ex-
tremities, particularly the lower legs and
feet.Hyperglycemiacausesnervetoxicity,
leading to nerve damage and apoptosis
(242,244), which causes microvascular
damage and loss of perfusion. Symptoms
manifest as neuropathic pain and/or loss
of sensation that, coupled with poor
blood ﬂow, increase the risk of foot inju-
ries and ulcerations (45,244). Up to 40%
of diabetic individuals may experience
peripheral neuropathy, and 60% of lower
extremity amputations in Americans are
related to diabetes (166,199,216).
Evidence statement. Individuals with
peripheral neuropathy and without acute
ulceration may participate in moderate
weight-bearing exercise. Comprehensive
footcareincludingdailyinspectionoffeet
and use of proper footwear is recom-
mended for prevention and early detec-
tion of sores or ulcers. Moderate walking
likely does not increase risk of foot ulcers
or reulceration with peripheral neuropa-
thy.ACSMevidencecategoryB.ADABlevel
recommendation.
Autonomic neuropathy. Moderate-
intensityaerobictrainingcanimproveau-
tonomic function in individuals with and
without CV autonomic neuropathy
(CAN) (112,176,208); however, im-
provements may only be evident after an
acute submaximal exercise (78). Screen-
ing for CAN should include a battery of
autonomic tests (including HR variabil-
ity) that evaluate both branches of the au-
tonomic nervous system. Given the
likelihood of silent ischemia, HR, and BP
abnormalities, individuals with CAN
should have physician approval and pos-
sibly undergo stress testing to screen for
CV abnormalities before commencing ex-
ercise(265).Exerciseintensitymaybeac-
curately prescribed using the HR reserve
method(apercentageofthedifferencebe-
tween maximal and resting HR, added to
the resting value) to approximate oxygen
consumption during submaximal exer-
cise with maximal HR directly measured,
rather than estimated, for better accuracy
(48,265).
Approximately 22% of those with
type 2 diabetes have CAN, but most ex-
hibit alterations in autonomic function
(292). The presence of CAN doubles the
risk of mortality (48,265) and indicates
more frequency of silent myocardial isch-
emia (265), orthostatic hypotension, or
resting tachycardia (76,177). CAN also
impairs exercise tolerance and lowers
maximal HR (131,265). Although both
sympathetic and parasympathetic dys-
functions can be present, vagal dysfunc-
tion usually occurs earlier. Slower HR
recovery after PA is associated with mor-
tality risk (38,265).
Evidence statement. Individuals with
CANshouldbescreenedandreceivephy-
sician approval and possibly an exercise
stress test before exercise initiation. Exer-
cise intensity is best prescribed using the
HR reserve method with direct measure-
ment of maximal HR. ACSM evidence cat-
egory C. ADA C level recommendation.
Retinopathy. In diabetic individuals
with proliferative or preproliferative reti-
nopathy or macular degeneration, careful
screening and physician approval are rec-
ommended before initiating an exercise
program. Activities that greatly increase
intraocular pressure, such as high-
intensity aerobic or resistance training
(with large increases in systolic BP) and
head-down activities, are not advised
with uncontrolled proliferative disease,
nor are jumping or jarring activities, all of
which increase hemorrhage risk (1). Dia-
betic retinopathy is the main cause of
blindness in developed countries and is
associated with increased CV mortality
(129,147). Individuals with retinopathy
may receive some beneﬁts, such as im-
proved work capacity, after low- to mod-
erate-intensity exercise training (16,17).
WhilePAhasbeenshowntobeprotective
against development of age-related mac-
ular degeneration (150), very little re-
search exists in type 2 diabetes.
Evidence statement. Individuals with
uncontrolled proliferative retinopathy
should avoid activities that greatly in-
crease intraocular pressure and hemor-
rhage risk. ACSM evidence category D.
ADA E level recommendation.
Nephropathy and microalbuminuria.
Both aerobic and resistance training im-
prove physical function and QOL in indi-
viduals with kidney disease (126,209,
210), although BP increases during PA
may transiently elevate levels of mi-
croalbumin in urine. Resistance exercise
training is especially effective in improv-
ing muscle function and activities of daily
living, which are normally severely af-
fectedbylater-stagekidneydisease(126).
Before initiation of PA, individuals with
overt nephropathy should be carefully
screened, have physician approval, and
possibly undergo stress testing to detect
CAD and abnormal HR and BP responses
(1,27). Exercise should be begun at a low
intensity and volume because aerobic ca-
pacity and muscle function are substan-
tially reduced, and avoidance of the
Valsava maneuver or high-intensity exer-
cisetopreventexcessiveincreasesinBPis
advised (1). Supervised, moderate aero-
bic exercise undertaken during dialysis
sessions, however, has been shown to be
effective as home-based exercise and may
improve compliance (126,151).
Diabetic nephropathy develops in
30% of individuals with diabetes and is
a major risk factor for death in those with
diabetes (20,45). Microalbuminuria, or
minute amounts of albumin in the urine,
is common and a risk factor for overt ne-
phropathy (45) and CV mortality (91).
Tight BG and BP control may delay pro-
gression of microalbuminuria (127,148),
along with exercise and dietary changes
(81,162). Exercise training delays the
progression of diabetic nephropathy in
animals (89,259), but few evidence is
available in humans.
Evidence statement. Exercise training
increases physical function and QOL in
individuals with kidney disease and may
even be undertaken during dialysis ses-
sions. The presence of microalbuminuria
per se does not necessitate exercise re-
strictions.ACSMevidencecategoryC.ADA
C level recommendation.
ADOPTION AND
MAINTENANCE OF
EXERCISE BY PERSONS
WITH DIABETES— Most American
adultswithtype2diabetesorathighestrisk
for developing it do not engage in regular
PA;theirrateofparticipationissigniﬁcantly
below national norms (193). Additional
strategies are needed to increase the adop-
tion and maintenance of PA.
One of the most consistent predictors
ofgreaterlevelsofactivityhasbeenhigher
levels of self-efﬁcacy (2,55,68), which re-
ﬂect conﬁdence in the ability to exercise
(185). Social support has also been asso-
ciated with greater levels of PA (93,
190,215), supporting the role of social
networks in the spread of obesity (41).
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may be exploited to increase the effects of
interventionsbeyondthe“target”individ-
ual(8,99)andpotentiallycanhelpspread
PA behavior. Counseling delivered by
health care professionals may be a mean-
ingful source of support and effective
source for delivery (7,144). Physicians
vary in counseling their patients to exer-
cise: on average, advice or referral related
toexerciseoccurredat18%ofofﬁcevisits
among diabetic patients (213), and 73%
of patients reported receiving advice at
some point to exercise more (192). The
availability of facilities or pleasant and
safe places to walk may also be important
predictors of regular PA (59).
When prescribing PA for the preven-
tion or control of type 2 diabetes, the ef-
fects of the dose of the prescription on
adherence are small (225). Therefore,
practitioners are encouraged to use fac-
tors such as choice and enjoyment in
helping determine speciﬁcally how an in-
dividual would meet recommended par-
ticipation. Affective responses to exercise
may be important predictors of adoption
and maintenance, and encouraging activ-
ity at intensities below the ventilatory
threshold may be most beneﬁcial
(172,277,278).Manyindividualswith,or
at risk of developing, type 2 diabetes pre-
fer walking as an aerobic activity (190),
and pedometer-based interventions can
be effective for increasing aerobic activity
(30,205,258). Finally, the emerging im-
portance of sedentary behaviors in deter-
mining metabolic risk (106,107) suggests
that future interventions may also beneﬁt
from attempting to decrease sitting time
and periods of extended sedentary
activity.
Large-scale trials such as the DPP and
Look AHEAD provide some insight into
successfullifestyleinterventionsthathelp
promotePAbyincorporatinggoalsetting,
self-monitoring, frequent contact, and
stepped-care protocols (56,60,71,266).
Deliveringtheseprogramsrequiresexten-
sive access to resources, staff, and space,
although they are cost-effective overall
(121,122).
These large studies are multifactorial,
targeting several behaviors that include
PA, but include multiple behavior inter-
ventions that also require changes in diet
and focusing on weight loss or manage-
ment (179). Therefore, strategies for PA
intervention in weight management are
highly relevant to this population (62).
Fewer RCTs solely targeted PA behavior
in individuals with or at risk of develop-
ing type 2 diabetes (279,284,285). The
results have been mixed, with some
showing increased PA (67,120,145,171)
and others showing no effect
(142,143,189). Effective short-term pro-
grams have used print (67), phone
(44,144,233), in-person (120,139), or
Internet (92,171) delivery. Long-term ef-
fectiveness of such interventions has not
been assessed (197).
Evidence statement. Efforts to promote
PA should focus on developing self-
efﬁcacy and fostering social support from
family,friends,andhealthcareproviders.
EncouragingmildormoderatePAmaybe
most beneﬁcial to adoption and mainte-
nance of regular PA participation. Life-
style interventions may have some
efﬁcacy in promoting PA behavior. ACSM
evidence category B. ADA B level
recommendation.
CONCLUSIONS— Exercise plays a
major role in the prevention and control
of insulin resistance, prediabetes, GDM,
type 2 diabetes, and diabetes-related
health complications. Both aerobic and
resistance training improve insulin ac-
tion, at least acutely, and can assist with
the management of BG levels, lipids, BP,
CV risk, mortality, and QOL, but exercise
must be undertaken regularly to have
continuedbeneﬁtsandlikelyincludereg-
ular training of varying types. Most per-
sons with type 2 diabetes can perform
exercise safely as long as certain precau-
tions are taken. The inclusion of an exer-
ciseprogramorothermeansofincreasing
overall PA is critical for optimal health in
individuals with type 2 diabetes.
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